Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience

[Image: see text] Background: Coronavirus disease 2019 (COVID-19), a multi-system disorder resulting from infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected 5.0 million individuals in the United States (US) resulting in more than 160,000 deaths. There is curren...

Descripción completa

Detalles Bibliográficos
Autores principales: Browning, Sabrina L., Gormally, Michael, Briggs, Neima, Li, Muyi, Zakko, Alan, Laurent-Rolle, Maudry, Ladines-Lim, Joseph, Morrison, Alyssa, Kandel, Prakash, Khan, Mohammad, McLeod, Gavin X., Buller, Gregory K., Owusu, Kent A., Treggiari, Miriam M., Hendrickson, Jeanne E., Tormey, Christopher A., Desruisseaux, Mahalia S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
401.Basic Science and Clinical Practice in Blood Transfusion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330251/
http://dx.doi.org/10.1182/blood-2020-137352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330251/
http://dx.doi.org/10.1182/blood-2020-137352

Ejemplares similares